Australia Daily Briefing

CSL dropped A$3.49 to $322.17, its worst single-session move in several weeks, dragging Healthcare to the bottom of the sector ladder at -1.07%. Quarter-end rebalancing is the most logical culprit — CSL remains a top-10 ASX weight and super funds trimming winners into September 30 is a consistent seasonal pattern. Watch for a bounce in early October once rebalancing flows clear; the fundamental story — Behring plasma volumes, Vifor nephrology ramp — remains intact.

MQBKY added 0.23% to $171.80, making it the session's standout in an otherwise flat market and confirming the Banks sector as the sole defensive green pocket at +0.23%. The divergence from CBA, NAB, WBC, and ANZ — which barely moved — suggests institutional preference for Macquarie's capital-markets and infrastructure revenue mix over pure NIM plays, especially with RBA rate-cut timing still uncertain. If AUD/USD stabilises above 0.6400 heading into Q4, Macquarie's offshore earnings translation gets an additional lift.

BHP gained a token $0.02 to $84.84 and RIO added $0.01 to $94.17 — essentially unchanged — while the broader Mining sector lost 0.49%, pointing to weakness in the mid-cap and gold names rather than the majors. NEM fell 1.49% to $115.34, the session's biggest loser, as gold's Q3 rally faces profit-taking pressure. China's September PMI data due imminently is the swing factor for iron ore; a sub-50 print would validate the hesitation in BHP and RIO and push Mining into a more sustained Q4 drawdown.